Quent Long Short Global Small Cap Fund LP Takes Position in McKesson Corporation $MCK

Quent Long Short Global Small Cap Fund LP acquired a new stake in shares of McKesson Corporation (NYSE:MCK) during the fourth quarter, HoldingsChannel reports. The firm acquired 1,142 shares of the company’s stock, valued at approximately $937,000.

A number of other institutional investors and hedge funds have also modified their holdings of the company. Obsidian Personal Planning Solutions LLC increased its stake in McKesson by 2.9% in the third quarter. Obsidian Personal Planning Solutions LLC now owns 426 shares of the company’s stock valued at $346,000 after acquiring an additional 12 shares during the period. IAM Advisory LLC increased its stake in McKesson by 0.3% in the third quarter. IAM Advisory LLC now owns 3,908 shares of the company’s stock valued at $3,019,000 after acquiring an additional 13 shares during the period. PDS Planning Inc increased its stake in McKesson by 1.1% in the third quarter. PDS Planning Inc now owns 1,209 shares of the company’s stock valued at $934,000 after acquiring an additional 13 shares during the period. Berkshire Asset Management LLC PA increased its stake in McKesson by 4.6% in the third quarter. Berkshire Asset Management LLC PA now owns 294 shares of the company’s stock valued at $227,000 after acquiring an additional 13 shares during the period. Finally, Norden Group LLC increased its stake in McKesson by 4.3% in the fourth quarter. Norden Group LLC now owns 317 shares of the company’s stock valued at $260,000 after acquiring an additional 13 shares during the period. 85.07% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of research firms recently weighed in on MCK. TD Cowen upped their target price on shares of McKesson from $1,000.00 to $1,012.00 and gave the company a “buy” rating in a research note on Thursday, February 5th. Morgan Stanley reiterated an “overweight” rating and issued a $966.00 price target on shares of McKesson in a research report on Thursday, January 29th. Raymond James Financial set a $970.00 price target on McKesson in a research report on Thursday, March 5th. Barclays upped their price target on McKesson from $960.00 to $1,050.00 and gave the company an “overweight” rating in a research report on Wednesday, February 18th. Finally, Wall Street Zen cut McKesson from a “buy” rating to a “hold” rating in a research report on Saturday, April 11th. Thirteen equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat.com, McKesson presently has a consensus rating of “Moderate Buy” and an average target price of $972.27.

Insider Activity at McKesson

In other news, EVP Michele Lau sold 2,725 shares of the stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an average price of $990.00, for a total transaction of $2,697,750.00. Following the sale, the executive vice president directly owned 3,247 shares of the company’s stock, valued at $3,214,530. This represents a 45.63% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Maria Martinez sold 349 shares of the stock in a transaction that occurred on Thursday, February 19th. The shares were sold at an average price of $939.87, for a total transaction of $328,014.63. Following the sale, the director directly owned 301 shares in the company, valued at $282,900.87. This trade represents a 53.69% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 3,592 shares of company stock valued at $3,518,555 over the last three months. 0.08% of the stock is owned by company insiders.

McKesson Trading Up 0.8%

Shares of McKesson stock opened at $835.97 on Friday. The stock has a market capitalization of $102.40 billion, a price-to-earnings ratio of 24.04, a P/E/G ratio of 1.20 and a beta of 0.42. McKesson Corporation has a 1-year low of $637.00 and a 1-year high of $999.00. The firm’s 50-day moving average price is $906.22 and its two-hundred day moving average price is $856.65.

McKesson (NYSE:MCK) last announced its earnings results on Wednesday, February 4th. The company reported $9.34 EPS for the quarter, topping the consensus estimate of $9.19 by $0.15. The company had revenue of $106.16 billion for the quarter, compared to analysts’ expectations of $105.98 billion. McKesson had a negative return on equity of 338.97% and a net margin of 1.09%.The business’s revenue for the quarter was up 11.4% on a year-over-year basis. During the same quarter in the prior year, the business earned $8.03 earnings per share. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. As a group, equities research analysts predict that McKesson Corporation will post 39.02 EPS for the current year.

McKesson Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, July 1st. Stockholders of record on Monday, June 1st will be paid a dividend of $0.82 per share. This represents a $3.28 annualized dividend and a dividend yield of 0.4%. The ex-dividend date of this dividend is Monday, June 1st. McKesson’s dividend payout ratio is 9.43%.

About McKesson

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.